BONESUPPORT reports strong Q3 sales growth
Net sales reached SEK 408.8 million. The company highlights SOLARIO study results and regulatory updates for CERAMENT products.
See the latest news and media coverage for BONESUPPORT. We track all announcements, press releases, and industry mentions in real time, all in one place.
Orthobiologics company focused on bone disorders
bonesupport.comLast updated
In short: BONESUPPORT reported strong Q3 2026 results and advanced CERAMENT U.S. regulatory and reimbursement access.
Net sales reached SEK 408.8 million. The company highlights SOLARIO study results and regulatory updates for CERAMENT products.
The Board authorizes the repurchase to optimize capital structure and increase shareholder value through potential cancellations by October 2026.
The final rule assigns CERAMENT G to highest reimbursing DRGs for complex orthopedic infections, effective October 1, 2026.
Net sales reached SEK 355.7 million driven by US CERAMENT G demand and EUROW strength with adjusted operating margin of 29 percent and cash position of SEK 434.3 million.
Medtech company Bonesupport reports an operating result of SEK 123 million for the third quarter (65.4).
BONESUPPORT reported that third-quarter sales increased by 39% compared to the previous year, while adjusted operating profit improved, thanks to higher...
Medical technology company Bonesupport reports an operating result of 123 million SEK (65.4) for the third quarter of 2026.
BONESUPPORT delivered strong Q3 2025 results with net sales of SEK 294 million, up 24% YoY (34% at constant currency). Adjusted operating margin reached 27...
Track BONESUPPORT and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BONESUPPORT and other trending companies.